Gossamer Bio, Inc. Common Stock (GOSS) Stock Price

GOSSStock

$0.20−92.52%52W

Market Cap$99.97M

P/E—

PEG Ratio—

Div yield—

Beta2.22

GOSS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-103.18%

Price vs S&P 500 (4W)-17.73%

VGM Score46.58

Book Value / Share (Quarterly)$0.13

P/TBV (Annual)14.41x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.73

Price vs S&P 500 (YTD)-106.31%

Net Profit Margin (TTM)-324.82%

EPS (TTM)$-0.78

10-Day Avg Trading Volume26.53M

EPS Excl Extra (TTM)$-0.78

EPS (Annual)$-0.75

ROI (Annual)-24.90%

Cash / Share (Quarterly)$0.42

Revenue Growth QoQ (YoY)71.45%

ROA (Last FY)-98.91%

Revenue Growth TTM (YoY)-55.42%

EBITD / Share (TTM)$-0.78

ROE (5Y Avg)-528.46%

Operating Margin (TTM)-321.92%

Cash Flow / Share (Annual)$-0.73

P/B Ratio2.80x

P/B Ratio (Quarterly)7.07x

Net Income / Employee (Annual)$-1,058,200

EV / Revenue (TTM)4.30x

Net Interest Coverage (TTM)-17.90x

ROA (TTM)-96.10%

EPS Incl Extra (Annual)$-0.75

Current Ratio (Annual)2.64x

Quick Ratio (Quarterly)1.92x

3-Month Avg Trading Volume21.88M

52-Week Price Return-92.52%

Revenue / Employee (TTM)$345,000

Tangible BV / Share (Quarterly)$0.46

P/S Ratio (Annual)1.68x

Asset Turnover (Annual)0.28x

52-Week High$3.87

EPS Excl Extra (Annual)$-0.75

CapEx CAGR (5Y)-44.50%

26-Week Price Return-91.94%

Quick Ratio (Annual)2.35x

13-Week Price Return-12.94%

Total Debt / Equity (Annual)6.70x

Current Ratio (Quarterly)2.20x

Enterprise Value$238.98M

Asset Turnover (TTM)0.30x

Book Value / Share Growth (5Y)-53.08%

Revenue / Employee (Annual)$301,100

Pretax Margin (Annual)-351.67%

Cash / Share (Annual)$0.59

3-Month Return Std Dev141.61%

Net Income / Employee (TTM)$-1,120,500

ROE (Last FY)-191.67%

Net Interest Coverage (Annual)-19.13x

EPS Basic Excl Extra (Annual)$-0.75

Receivables Turnover (TTM)7.01x

Total Debt / Equity (Quarterly)6.83x

EPS Incl Extra (TTM)$-0.78

ROI (TTM)-23.00%

P/S Ratio (TTM)1.46x

Revenue / Share (Annual)$0.21

Tangible BV / Share (Annual)$0.13

Price vs S&P 500 (52W)-110.83%

Year-to-Date Return-94.35%

5-Day Price Return22.29%

EPS Normalized (Annual)$-0.75

ROA (5Y Avg)-65.35%

Net Profit Margin (Annual)-351.49%

Month-to-Date Return3.24%

Cash Flow / Share (TTM)$-1.55

EBITD / Share (Annual)$-0.75

Operating Margin (Annual)-352.23%

LT Debt / Equity (Annual)6.70x

ROI (5Y Avg)-63.48%

LT Debt / Equity (Quarterly)6.81x

EPS Basic Excl Extra (TTM)$-0.78

P/TBV (Quarterly)1.66x

P/B Ratio (Annual)6.95x

Pretax Margin (TTM)-324.98%

Book Value / Share (Annual)$0.13

Price vs S&P 500 (13W)-15.73%

Beta2.22x

P/FCF (Annual)4062.32x

Revenue / Share (TTM)$0.24

ROE (TTM)-118.77%

52-Week Low$0.11

vGradeB

gGradeC

mGradeD

vgmGradeC

GOSS Earnings Surprise History

Q2 25-0.17est. -0.18

Q3 25-0.21est. -0.20

Q4 25-0.21est. -0.20

Q1 26-0.20est. -0.17

Q2 26-0.10est. -0.12

GOSS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.69

3.64

3.79

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
GOSSGossamer Bio, Inc. Common Stock	B	C	D	$0.20
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Gossamer Bio, Inc. Common Stock

Gossamer Bio is a clinical-stage biopharmaceutical company developing therapeutics in immunology, inflammation, and oncology. Its pipeline includes Seralutinib for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB1275 for oncology indications, and GB001 for eosinophilic asthma.